BECATTINI, Cecilia
 Distribuzione geografica
Continente #
NA - Nord America 8.906
AS - Asia 5.704
EU - Europa 4.602
SA - Sud America 1.180
Continente sconosciuto - Info sul continente non disponibili 531
AF - Africa 150
OC - Oceania 5
Totale 21.078
Nazione #
US - Stati Uniti d'America 8.556
SG - Singapore 2.710
IT - Italia 971
BR - Brasile 888
IE - Irlanda 819
CN - Cina 773
RU - Federazione Russa 766
HK - Hong Kong 696
VN - Vietnam 615
UA - Ucraina 360
FR - Francia 341
DE - Germania 340
SE - Svezia 277
FI - Finlandia 219
GB - Regno Unito 184
CA - Canada 156
BD - Bangladesh 154
IN - India 139
KR - Corea 132
TR - Turchia 90
AR - Argentina 88
MX - Messico 77
IQ - Iraq 65
AT - Austria 55
PL - Polonia 49
PK - Pakistan 47
CO - Colombia 44
EC - Ecuador 43
ES - Italia 42
NL - Olanda 41
VE - Venezuela 37
ZA - Sudafrica 37
JP - Giappone 36
UZ - Uzbekistan 34
CH - Svizzera 30
CL - Cile 28
ID - Indonesia 27
SA - Arabia Saudita 25
CR - Costa Rica 22
JO - Giordania 21
TN - Tunisia 21
PH - Filippine 20
EG - Egitto 19
LB - Libano 19
JM - Giamaica 17
LT - Lituania 17
MA - Marocco 17
KE - Kenya 16
PE - Perù 14
PY - Paraguay 14
AE - Emirati Arabi Uniti 13
BE - Belgio 13
GT - Guatemala 13
MY - Malesia 11
BO - Bolivia 10
CZ - Repubblica Ceca 10
IL - Israele 10
UY - Uruguay 10
GR - Grecia 9
MK - Macedonia 9
PR - Porto Rico 9
PS - Palestinian Territory 9
SV - El Salvador 9
TT - Trinidad e Tobago 9
BG - Bulgaria 8
DZ - Algeria 8
OM - Oman 8
RO - Romania 8
CW - ???statistics.table.value.countryCode.CW??? 7
HN - Honduras 7
NP - Nepal 7
AZ - Azerbaigian 6
DK - Danimarca 6
ET - Etiopia 6
GP - Guadalupe 6
KG - Kirghizistan 6
BB - Barbados 5
EE - Estonia 5
NI - Nicaragua 5
AL - Albania 4
AM - Armenia 4
AO - Angola 4
CI - Costa d'Avorio 4
EU - Europa 4
GE - Georgia 4
KH - Cambogia 4
KW - Kuwait 4
PT - Portogallo 4
RS - Serbia 4
GY - Guiana 3
KZ - Kazakistan 3
SN - Senegal 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
BW - Botswana 2
BY - Bielorussia 2
CU - Cuba 2
DO - Repubblica Dominicana 2
GA - Gabon 2
Totale 20.515
Città #
Singapore 1.941
San Jose 914
Chandler 887
Dublin 812
Ashburn 754
Hong Kong 693
San Mateo 381
Santa Clara 333
Council Bluffs 320
Dong Ket 295
Moscow 295
Boardman 254
Altamura 228
Perugia 227
Lauterbourg 214
Princeton 205
Medford 204
Lawrence 194
Jacksonville 182
Beijing 176
Los Angeles 151
New York 146
Ann Arbor 133
Seoul 132
Ho Chi Minh City 131
Wilmington 130
Munich 113
Des Moines 112
Andover 103
Dallas 103
São Paulo 88
The Dalles 82
Hanoi 70
Piscataway 68
Helsinki 63
North Bergen 60
Redmond 55
Phoenix 53
San Paolo di Civitate 53
Orem 49
Nuremberg 48
Chicago 47
Montreal 46
Frankfurt am Main 44
Saint Petersburg 42
Rome 41
Izmir 40
Norwalk 39
Turku 38
Brooklyn 35
Toronto 34
Warsaw 32
Atlanta 31
Denver 31
Shanghai 31
Stockholm 29
Baghdad 28
Charlotte 27
Rio de Janeiro 27
Tokyo 27
Columbus 26
Houston 26
Milan 26
New Orleans 26
Hefei 25
Falls Church 24
San Francisco 24
Chennai 23
Boston 22
Buffalo 22
Lahore 21
London 21
Amelia 20
Bologna 20
Johannesburg 20
Naples 20
Brasília 19
Manchester 19
San José 19
Seattle 19
Tashkent 19
Amman 17
Redwood City 17
Amsterdam 16
Mexico City 16
Nairobi 15
Philadelphia 15
Quito 15
Vienna 15
Belo Horizonte 14
Da Nang 14
Mumbai 14
Dhaka 13
New Delhi 13
Ribeirão Preto 13
Riverbank 13
Woodbridge 13
Bogotá 12
Brussels 12
Caracas 12
Totale 12.851
Nome #
The sentinel node biopsy in patients with thick melanoma:outcome analysis from a single-institution database 171
Prognostic role of sentinel node biopsy in patients with thick melanoma: a meta-analysis. 158
Bedside sonography assessment of extravascular lung water increase after major pulmonary resection in non-small cell lung cancer patients 155
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model 152
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients 150
Aspirin for preventing the recurrence of venous thromboembolism. 147
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 144
Prestroke CHA2DS2-VASc Score and Severity of Acute Stroke in Patients with Atrial Fibrillation: Findings from RAF Study 133
Acute pulmonary embolism: external validation of the 2014 risk stratification model of the European Society of Cardiology 132
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 130
Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study 130
Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study 130
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 129
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 128
Definition of major bleeding: Prognostic classification 125
Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation) 122
96 hours ECGmonitoring for patients with ischemic cryptogenic stroke or transient ischaemicattack. 121
[ANMCO Position paper: Recommendations for the follow-up of patients with pulmonary thromboembolism] 120
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients with Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study 120
Acute cardiovascular events in patients with community acquired pneumonia: results from the observational prospective FADOI-ICECAP study 119
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study 118
A prospective study on cardiovascular events after acute pulmonary embolism 117
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism 117
Patients aged 90  years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study 117
Acute pulmonary embolism: external validation of an integrated risk stratification model. 115
A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. 115
Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis 114
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) 114
Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation 114
Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) Study 113
A new strategy for anticoagulation: The factor XI inhibitors 112
Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study 112
Risk factors for adverse short-term outcome in patients with pulmonary embolism 111
D-dimer for riskstratification in patients with acute pulmonary embolism. 111
[ANMCO position paper: Use of new oral anticoagulants for the treatment and prevention of pulmonary thromboembolism] 111
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al 111
ECOGRAFICA TRANS-TORACICA NELLA VALUTAZIONE DEI FLUIDI POLMONARI EXTRAVASCOLARI DOPO CHIRURGIA TORACICA MAGGIORE 110
Safety of Anticoagulation in Patients Treated with Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation 110
Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials 109
Incidence of venous thromboembolism in patients undergoing laparoscopic surgery for colorectal cancer 109
Association of Neutrophil Activation, More Than Platelet Activation, with Thrombotic Complications in Coronavirus Disease 2019 109
Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events 108
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 108
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation 108
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism 108
Initial treatment of venous thromboembolism 107
Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcme-based meta-analysis 107
Acute pulmonary embolism. 106
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: Systematic review and meta-analysis 106
Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis 106
Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis. 106
Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study 104
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 104
[Determinants of prognosis in acute pulmonary embolism: the role of serum troponins]. 104
Acute pulmonary embolism: risk stratification in the emergency department. 104
Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy 104
Aspirin for the prevention of recurrent venous thromboembolism the INSPIRE collaboration 103
Apixaban for the treatment of venous thromboembolism associated with cancer 103
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS) 103
Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy 102
Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation 102
Incomplete echocardiographic recovery at 6 months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial 102
Rivaroxaban for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer. Design of the PRO-LAPS II STUDY 102
Acute Pulmonary Embolism after Discharge: Duration of Therapy and Follow-up Testing 99
Venous thromboembolism and atherosclerosis: common denominators or different diseases? 98
PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort 98
Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism 98
Reperfusion therapies in patients with acute ischaemic stroke and atrial fibrillation: data on safety and effectiveness from a multi-centre cohort study 98
Prognostic value of respiratory index in haemodynamically stable patients with acute pulmonary embolism: The Respiratory Index model study 97
Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding 97
Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism 97
PREvention of VENous Thromboembolism in Hemorrhagic Stroke Patients-PREVENTIHS Study: A Randomized Controlled Trial and a Systematic Review and Meta-Analysis 97
Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation 97
New anticoagulants 96
Vitamin K and non-vitamin K antagonists oral anticoagulants for non-valvular atrial fibrillation in real-life 96
A Randomized Study on 1-Week Versus 4-Week Prophylaxis for Venous Thromboembolism After Laparoscopic Surgery for Colorectal Cancer Reply 96
Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer 96
Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis 96
Platelets from COVID-19 Patients Show an Altered Nitric Oxide/Reactive Oxygen Species Production Balance 95
Multidetector CT scan for acute pulmonary embolism: Embolic burden and clinical outcome 95
Efficacy and safety of two heparin regimens for prevention of venous thromboembolism in hospitalized patients with COVID-19: a meta-analysis 94
Oxygen saturation or respiratory rate to improve risk stratification in hemodynamically stable patients with acute pulmonary embolism 94
ANMCO statement: Arterial and venous thromboembolism: What implications for clinical practice? 94
Rivaroxaban versus placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer 94
Direct thrombin inhibitors for the prevention of venous thromboembolism after major orthopaedic surgery 93
Direct oral anticoagulants in patients with VTE and cancer: A systematic review and meta-analysis 93
Association of Neutrophil Activation, More Than Platelet Activation, with Thrombotic Complications in Coronavirus Disease 2019 93
Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study 92
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study 92
Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study 92
Cardiovascular risk factors and venous thromboembolism: a meta-analysis. 92
Acute treatment of venous thromboembolism 92
Thrombolysis in submassive pulmonary embolism 92
A platelet lipidomics signature in patients with COVID-19 91
The risk of stroke recurrence in patients with atrial fibrillation and reduced ejection fraction 91
Recurrent venous thromboembolism in men and women 91
Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism 91
Combined oral anticoagulants and antiplatelets: benefits and risks. 91
Padua prediction score or clinical judgment for decision making on antithrombotic prophylaxis: a quasi-randomized controlled trial 90
Lo studio EINSTEIN CHOICE 90
Totale 10.880
Categoria #
all - tutte 104.584
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.584


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.260 0 0 0 50 81 19 14 457 52 111 220 256
2022/20233.014 221 658 38 206 233 347 0 110 1.063 13 91 34
2023/20241.065 80 110 71 15 12 5 261 32 67 59 212 141
2024/20253.286 24 270 89 152 383 253 139 258 685 214 523 296
2025/20267.312 585 519 428 952 980 554 1.299 383 666 573 260 113
2026/20272.628 184 340 558 1.546 0 0 0 0 0 0 0 0
Totale 21.078